Article
Evidence based appropriate triage strategies for implementing high risk HPV as primary technology in cervical cancer screening.
Minerva ginecologica - 1 Apr 2020
Pimple Sharmila A, Mishra Gauravi A, Deodhar Kedar K
Abstract excerpt
Primary cervical cancer screening by HPV testing for high risk human papillomavirus (hrHPV) is expected to replace cytology-based programs in many parts of the world. Its high sensitivity and negative predictive value permit longer screening intervals up to beyond five years. However, low positive predictive value can lead to unnecessary referrals and overtreatment since most hrHPV infections are transient and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
